Within this essay, I will be Demonstrating, by making reference to studies, how psychological research has contributed to our understanding of the treatment for depression. I feel I have achieved this by outlining the studies listed below that contribute to the treatment of depression. I have also given my views on the studies, positive and negative.
My first research finding was in regards to different phases of depression and individuals responding different to treatment. This study was implemented by researchers at the University of Adelaide. The researchers revealed that not “one size fits all” when dealing with clinical depression.
Head of psychiatry at the university, professor Bernhard Baune, expressed “depression is much more complex …show more content…
The researchers then operated a systematic analysis of the current literature, which introduced them to the eventuality that there are diverse immune factors functioning in depression, depending on the clinical phase. Dr Baune then explained that what is seen in the clinical state of acute depression, relapse, remission and recovery is a very perplexing co-operation between inflammatory and other immunological cells, brain cells and systems. Therefore, this evidence showcases that it is essential to acknowledge individual components when deciding on treatment as each case is particular and may not reciprocate to the same …show more content…
These patients had major depressive disorder and were followed up 18 months after their treatment in regards to their depressive symptoms. CBT, Interpersonal Therapy, Imipramine Therapy or Placebo Plus was randomly assigned to these patients over a 16 week period. 30% of patients allocated to CBT recovered, 26% of patients allocated to Interpersonal Therapy recovered, 19% for those in Imipramine Plus and 20 % for those in Placebo Plus. This shows that the results did not vary much between the four treatments. The percentages are patients who had miner or no symptoms coming to the end of their treatment and had no depressive disorder relapse. However, rates of major depressive relapse were 36% for CBT, 33% for Interpersonal Therapy, 50% for imipramine Plus and 33% for Placebo Plus. These percentages clearly highlight that 16 weeks for treatment is unsatisfactory for patients to fully neither recover nor remain recovered. This study exposes the time restraint with treatment and shows that, in most cases, more time is needed. Allowing more time for patients could enable them to fully recover and reduce the risk of
My first research finding was in regards to different phases of depression and individuals responding different to treatment. This study was implemented by researchers at the University of Adelaide. The researchers revealed that not “one size fits all” when dealing with clinical depression.
Head of psychiatry at the university, professor Bernhard Baune, expressed “depression is much more complex …show more content…
The researchers then operated a systematic analysis of the current literature, which introduced them to the eventuality that there are diverse immune factors functioning in depression, depending on the clinical phase. Dr Baune then explained that what is seen in the clinical state of acute depression, relapse, remission and recovery is a very perplexing co-operation between inflammatory and other immunological cells, brain cells and systems. Therefore, this evidence showcases that it is essential to acknowledge individual components when deciding on treatment as each case is particular and may not reciprocate to the same …show more content…
These patients had major depressive disorder and were followed up 18 months after their treatment in regards to their depressive symptoms. CBT, Interpersonal Therapy, Imipramine Therapy or Placebo Plus was randomly assigned to these patients over a 16 week period. 30% of patients allocated to CBT recovered, 26% of patients allocated to Interpersonal Therapy recovered, 19% for those in Imipramine Plus and 20 % for those in Placebo Plus. This shows that the results did not vary much between the four treatments. The percentages are patients who had miner or no symptoms coming to the end of their treatment and had no depressive disorder relapse. However, rates of major depressive relapse were 36% for CBT, 33% for Interpersonal Therapy, 50% for imipramine Plus and 33% for Placebo Plus. These percentages clearly highlight that 16 weeks for treatment is unsatisfactory for patients to fully neither recover nor remain recovered. This study exposes the time restraint with treatment and shows that, in most cases, more time is needed. Allowing more time for patients could enable them to fully recover and reduce the risk of